Diabetes Care Devices Market Insights, Research and Growth Factor till 2032

With a 6.3% CAGR from 2022 to 2032, the global diabetes care devices market is expected to be worth US$ 9.7 billion in 2022 and US$ 17.87 billion by 2032. The diabetes care devices market is being driven by rising diabetes cases and increased use of insulin delivery devices.

Changes in urbanisation, a growing preference for a fast-paced urban and sedentary lifestyle combined with an unhealthy diet, and an increase in diabetes cases have increased global sales of diabetes care devices. Furthermore, technological advancements in diabetes care devices drive market growth.

Obesity, sedentary lifestyle, and poor diet, among other factors, are to blame for the rise in diabetics. Diabetes care device demand is expected to increase throughout the assessment period due to the rising prevalence of the disease and the high number of deaths - 6.7 million deaths in 2021 - caused by the disease.

Key Takeaways:

  • Market growth is being driven by an ageing population, laxer regulations, and more affordable labour.
  • Demand for diabetes care devices is being driven by the release of high-end insulin pumps and pens.
  • Diabetes care device demand is being driven by Asia Pacific and the Middle East.
  • The rapid expansion of the construction industry in China and India will expand market opportunities in the region.
  • Diabetes management mobile applications are expected to grow rapidly.
  • The market will be dominated by hospitals and specialty clinic setups.

Know More About Report@ https://www.futuremarketinsights.com/reports/diabetes-care-devices-market

Competitive Landscape 

Abbott Laboratories, ACON Laboratories, Inc., Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Company, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Medtronic plc, Novo Nordisk A/S, Terumo Corporation.

Key Segments

By Type:

  • Blood glucose monitoring systems
  • Self-monitoring blood glucose monitoring systems
  • Continuous glucose monitoring systems
    • Test strips/Test papers
    • Lancets/Lancing devices
  • Insulin delivery devices
    • Insulin pumps
    • Insulin pens
    • Insulin syringes and needles
  • Diabetes management mobile applications

By Patient Care Settings:

  • Hospitals & specialty clinics
  • Self & home care

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more